Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why Inhibrx Stock Is on the Move Today

TheMotleyFool

0 0

Here's Why Inhibrx Stock Is on the Move Today

Shares of Inhibrx (NASDAQ: INBX), a clinical-stage biotechnology company, jumped when the market opened today. Investors excited about the company's latest clinical trial readout pushed the stock 26.8% higher as of 11:29 a.m. on Tuesday.

Today, Inhibrx reported top-line data from a phase 1 trial with INBRX-101. This is the company's specialized version of alpha-1 antitrypsin (AAT), a protein that protects lung tissue.

Image source: Getty Images.

Source Fool.com

Like: 0

INBX

Share